Publications | Page 5 | Cervo Brain Research Centre

Export 4 results:

Filters: Author is Bouchard, R H [Clear All Filters]

2007

Y. C. Chagnon, Bureau, A., Gendron, D., Bouchard, R. H., Mérette, C., M-A Roy, and Maziade, M., “Possible association of the pro-melanin-concentrating hormone gene with a greater body mass index as a side effect of the antipsychotic olanzapine.”, Am J Med Genet B Neuropsychiatr Genet, vol. 144B, no. 8, pp. 1063-9, 2007.

2001

R. H. Bouchard, Demers, M. - F., Simoneau, I., Alméras, N., Villeneuve, J., Mottard, J. P., Cadrin, C., Lemieux, I., and Després, J. P., “Atypical antipsychotics and cardiovascular risk in schizophrenic patients.”, J Clin Psychopharmacol, vol. 21, no. 1, pp. 110-1, 2001.

2000

R. H. Bouchard, Mérette, C., Pourcher, E., Demers, M. - F., Villeneuve, J., Roy-Gagnon, M. H., Gauthier, Y., Cliche, D., Labelle, A., Filteau, M. J., M-A Roy, and Maziade, M., “Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia. The Quebec Schizophrenia Study Group.”, J Clin Psychopharmacol, vol. 20, no. 3, pp. 295-304, 2000.

I. Simoneau, Villeneuve, J., Demers, M. - F., and Bouchard, R. H., “[Schizophrenia and psychoactive drug abuse: dual diagnostic problem].”, Can J Psychiatry, vol. 45, no. 6, pp. 572-3, 2000.

Funding / Support / Partners

© Gouvernement du Québec